Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice-Reference-Cited by-同舟云学术

Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice

Published:2014-11-18 Issue:6 Volume:16 Page:878-886
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Ariza-Heredia E.J.¹,Gulbis A.M.²,Stolar K.R.³,Kebriaei P.³,Shah D.P.¹,McConn K.K.¹,Champlin R.E.³,Chemaly R.F.¹

Affiliation:

1. Department of Infectious Diseases, Infection Control and Employee Health; The University of Texas MD Anderson Cancer Center; Houston Texas USA

2. Division of Pharmacy; The University of Texas MD Anderson Cancer Center; Houston Texas USA

3. Department of Stem Cell Transplantation and Cellular Therapy; The University of Texas MD Anderson Cancer Center; Houston Texas USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12312/fullpdf

Reference40 articles.

1. Immunity after (re)vaccination of paediatric patients following haematopoietic stem cell transplantation;Olkinuora;Acta Paediatr,2012

2. The detection of specific antibody formation to recall antigens after human bone marrow transplantation;Lum;Blood,1986

3. Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation;Ljungman;Blood,1994

4. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey;Engelhard;Br J Haematol,2002

5. Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation;Aucouturier;Blood,1987

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facilitators and Barriers to Successful Revaccination after Hematopoietic Stem Cell Transplantation among Adult Survivors: A Scoping Review;Transplantation and Cellular Therapy;2023-11

2. Real-world challenges in eligibility for MMR vaccination two years after autologous and allogeneic HSCT;Vaccine;2023-09

3. Compliance with yellow fever and measles vaccines in the revaccination program post‐hematopoietic cell transplantation;Transplant Infectious Disease;2023-07-10

4. Improving the Quality of Healthcare Provision Regarding HPV Immunization for Women with CIN2+ Lesions: The Experience of the Veneto Region in Italy;Vaccines;2023-03-29

5. Vaccination of Immunocompromised Hosts;Plotkin's Vaccines;2023